Thus, carnitine deficiency, carnitine palmitoyltransferase (CPT) I or II deficiency, carnitine translocase deficiency, b-oxidation defects, or pyruvate carboxylase deficiency should be screened before initiating the KD treatment. The gene discussed is PC; the disease is hyperinsulinemic hypoglycemia, familial, 4.